| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.7M | -84.8% | +13.8% |
| R&D Expense | $39.9M | +4.0% | -35.8% |
| SG&A Expense | $8.7M | -15.5% | -39.0% |
| Operating Income | -$48.5M | -1348.7% | +28.7% |
| Pre-tax Income | -$56.9M | -393.7% | -16.5% |
| Income Tax | $0 | +100.0% | — |
| Net Income | -$56.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $65.9M | +3.0% | -62.2% |
| Short-term Investments | $101.7M | -27.9% | -52.4% |
| Accounts Receivable | $3.9M | -51.0% | -41.1% |
| Current Assets | $182.1M | -21.4% | -55.1% |
| Total Assets | $209.7M | -20.1% | -53.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$150.8M | — | — |
| Investing Cash Flow | $26.3M | — | — |
| Financing Cash Flow | $108K | — | — |
| -16.5% |
| EPS (Basic) | -$0.67 | -378.6% | -13.6% |
| EPS (Diluted) | -$0.67 | -378.6% | -13.6% |
| $71.9M |
| -3.2% |
| -45.2% |
| Total Liabilities | $296.9M | +0.8% | -12.8% |
| Stockholders' Equity | -$87.3M | -171.8% | -178.5% |